KVC in the News
RealClear Health 01.15.2026
Sanders Blocks Bipartisan Pediatric Cancer Bill
Sam Stein, 12.19.2025
House passes unanimously
12.1.25
Senate vote blocked
12.19.25
The Cancer Letter, 03.17.2025
Daily Beast, March 2025
BIOCENTURY, January 8, 2025
Political petulance, complacency halt pediatric priority review program
STAT News, September 12, 2024
A rare disease program, portrayed as both lifeline and pharma handout, is set to expire
The New York Times, December 20, 2024
Transition Updates: Senate Approves Stopgap Funding Bill Just After Shutdown Deadline
STAT News, December 20, 2024
Republicans dropped measures to help kids with cancer from the spending bill. Democrats pounced.
Newsweek, December 20, 2024
Pediatric Cancer Community ‘Devastated’ as Funds Removed From Spending Bill
The Bullwark, December 19, 2024
Elon Killed the Budget Deal. Cancer Research for Kids Was Collateral Damage.
Wake Up to Politics, September 27, 2024
Federal Register, September 19, 2024
FDA Sets New Priority Review User Fee Rate for FY 2025: $2,482,446
STAT News, September 12, 2024
A rare disease program, portrayed as both lifeline and pharma handout, is set to expire
Pink Sheet, January 5, 2023
How To Get A Bill Through Congress: Pediatric Cancer Treatment Advocate Scores 2 Wins, 1 Loss
The Washington Post, August 5, 2022
The Lancet, August 2022
New Legislation to Promote Paediatric Studies for New Cancer Medicines
Pink Sheet, May 18, 2022
US FDA Could Require Pediatric Cancer Drug Combo Studies Under Amended User Fee Bill
Bloomberg Law, May 18, 2022
Nature Medicine, April 19, 2022
How to Correct the Market for Children’s Cancer Drugs, by Nancy Goodman